Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IRBESARTAN | 300MG | TABLET | Resolved | 2019-07-02 | 2021-09-10 | 88171 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2019-08-22 | 2021-05-06 | 92171 |
| TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2019-09-19 | 2021-09-10 | 94369 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2023-06-08 | 2023-11-03 | 194135 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Resolved | 2023-06-08 | 2024-04-11 | 194138 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195588 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195609 |
| TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2023-10-05 | 2023-11-03 | 206422 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2024-01-25 | 2024-04-01 | 217234 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68619 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68622 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88174 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2019-10-24 | 2019-11-28 | 97153 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2019-12-05 | 2021-09-10 | 100305 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-12-19 | 2021-09-10 | 101725 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-04-10 | 2021-03-04 | 111865 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-07-14 | 2020-07-15 | 120235 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-09-22 | 2021-03-04 | 124743 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2021-03-11 | 2021-05-06 | 135555 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2021-06-10 | 2021-09-10 | 140681 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |